Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in shares of Cigna Corp (NYSE:CI) by 9.9% in the third quarter, HoldingsChannel reports. The fund owned 23,528 shares of the health services provider’s stock after purchasing an additional 2,116 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Cigna were worth $3,571,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of the stock. Joel Isaacson & Co. LLC purchased a new stake in Cigna during the third quarter valued at approximately $2,998,000. Wealthfront Advisers LLC lifted its position in Cigna by 43.6% during the third quarter. Wealthfront Advisers LLC now owns 7,652 shares of the health services provider’s stock valued at $1,161,000 after acquiring an additional 2,325 shares during the last quarter. Private Capital Advisors Inc. lifted its position in Cigna by 1.2% during the third quarter. Private Capital Advisors Inc. now owns 68,290 shares of the health services provider’s stock valued at $10,366,000 after acquiring an additional 830 shares during the last quarter. Beacon Financial Group lifted its position in Cigna by 2.9% during the third quarter. Beacon Financial Group now owns 2,929 shares of the health services provider’s stock valued at $438,000 after acquiring an additional 83 shares during the last quarter. Finally, Roman Butler Fullerton & Co. lifted its position in Cigna by 2.6% during the third quarter. Roman Butler Fullerton & Co. now owns 9,073 shares of the health services provider’s stock valued at $1,377,000 after acquiring an additional 231 shares during the last quarter. 87.44% of the stock is owned by institutional investors.
A number of equities research analysts recently commented on the stock. Deutsche Bank assumed coverage on shares of Cigna in a research report on Thursday, September 12th. They set a “buy” rating and a $207.00 target price for the company. Raymond James upped their price target on shares of Cigna from $185.00 to $190.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. BMO Capital Markets upgraded shares of Cigna from a “market perform” rating to an “outperform” rating and set a $188.00 price target on the stock in a research note on Monday, September 30th. ValuEngine upgraded shares of Cigna from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Citigroup restated a “buy” rating on shares of Cigna in a research note on Wednesday, August 21st. Three equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $210.77.
In other Cigna news, CEO David Cordani acquired 32,509 shares of the business’s stock in a transaction dated Monday, September 9th. The shares were purchased at an average price of $155.17 per share, for a total transaction of $5,044,421.53. 0.80% of the stock is owned by corporate insiders.
Shares of Cigna stock opened at $161.47 on Thursday. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.84. Cigna Corp has a 12-month low of $141.95 and a 12-month high of $226.60. The firm has a market capitalization of $57.24 billion, a price-to-earnings ratio of 11.36, a PEG ratio of 0.77 and a beta of 0.71. The firm’s 50 day simple moving average is $154.96 and its two-hundred day simple moving average is $159.07.
Cigna (NYSE:CI) last issued its quarterly earnings results on Thursday, August 1st. The health services provider reported $4.30 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.74 by $0.56. The business had revenue of $34.38 billion for the quarter, compared to analyst estimates of $33.27 billion. Cigna had a net margin of 3.60% and a return on equity of 13.24%. Cigna’s revenue for the quarter was up 198.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.89 EPS. On average, sell-side analysts predict that Cigna Corp will post 16.77 EPS for the current fiscal year.
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Story: How is Preferred Stock Different from Common Stock?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.